Vaccination

AstraZeneca Covid vaccine sales hit $275 mn in first quarter

British pharmaceuticals giant AstraZeneca said Friday that its COVID vaccine generated $275 million (227 million euros) in sales in the first quarter, as its chief executive defended the company's performance in the face ...

Vaccination

EU hints it might not order AstraZeneca jab again

The EU's internal markets commissioner Thierry Breton hinted Sunday that the bloc might decide not to order AstraZeneca's coronavirus jab again following delays in delivering the first batches of the vaccine.

Diseases, Conditions, Syndromes

Real-world proof that Pfizer, Moderna vaccines slash COVID infections

(HealthDay)—The two-dose mRNA vaccines from Pfizer and Moderna have proven to be potent weapons against COVID-19 infection among health care workers, first responders and essential workers in the real world, a new U.S. ...

Diseases, Conditions, Syndromes

Europe can achieve herd immunity by July: EU commissioner

Europe could have herd immunity against COVID-19 by July, a European Union commissioner has said, as incoming jabs are expected to speed up the continent's sluggish vaccine rollout.

Vaccination

BioNTech/Pfizer say vaccine can stand warmer temperatures

Germany's BioNTech and its US partner Pfizer on Friday said tests have shown that their coronavirus vaccine can stand warmer temperatures than initially thought, potentially simplifying the jab's complex cold-chain logistics.

page 4 from 7